1 Introduction Short interfering ribonucleic acid (siRNA) downregulates the expression of targeted, disease-driving genes [1] by binding to the RNA-induced silencing complex (RISC) in the cytoplasm. Therefore, following endocytosis, escape from the endo-lysosomal pathway is essential to achieve a therapeutic effect [2]. A broad range of strategies has been developed to formulate potent nanoparticles for nucleic acid delivery [3, 4], including the use of polycationic polymers [5, 6].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile